DDInter948 DDInter416
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
This drug is a broad spectrum antimycotic or antifungal agent. Clotrimazole's antimycotic properties were discovered in the late 1960s . Clotrimazole falls under the _imidazole_ category of _azole_ antifungals, possessing broad-spectrum antimycotic activity . It is available in various preparations, including creams, pessaries, and troche formulations (slowly dissolving tablets). As well as its antifungal activity, clotrimazole has become a drug of interest in treating several other diseases such as sickle cell disease, malaria and some cancers . The minimal side effect profile of this drug and its uncomplicated metabolic profile have led it to gain widespread acceptance for the treatment of mycotic outbreaks such as vaginal yeast infections as well as athlete's foot .
Clotrimazole {u} (Compound) resembles {v} (Compound) Methadone
Clotrimazole {u} (Compound) resembles {v} (Compound) Diphenidol
Clotrimazole {u} (Compound) binds {v} (Gene) CYP2C9
Clotrimazole {u} (Compound) upregulates {v} (Gene) PCK2
Clotrimazole {u} (Compound) is included by {v} (Pharmacologic Class) Azoles
Clotrimazole {u} (Compound) causes {v} (Side Effect) Dermatitis bullous
Clotrimazole (Compound) resembles Methadone (Compound)
Clotrimazole (Compound) resembles Diphenidol (Compound)
Clotrimazole (Compound) binds CYP2C9 (Gene)
Clotrimazole (Compound) upregulates PCK2 (Gene)
Clotrimazole (Compound) is included by Azoles (Pharmacologic Class)
Clotrimazole (Compound) causes Dermatitis bullous (Side Effect)